Acellular normothermic ex vivo lung perfusion (EVLP) is an emerging strategy of clinical lung preservation which allows for additional donor lung evaluation and therapy.
using TRIzol reagent (Life Technologies, Rockville, MD) and RNA quality confirmed by spectrophotometric analysis (OD 260/280 ) and by the Agilent 2100 bioanalyzer to obtain an RNA integrity number (RIN). One lung with poor quality RNA was excluded from the study.
7.5 μg of RNA was hybridized to the microarray as described by the manufacturer.
Expression data were obtained from the resulting Affymetrix .cel files using the Affy package from the Bioconductor suite for R. 8, 9 We utilized the robust multi-array average (RMA) technique for preprocessing with quantile normalization and median polish.
We utilized the Short Time-series Expression Miner (STEM) software by Ernst et al for clustering and filtering genes with a significant time-dependence to their expression. 10 To verify results obtained by STEM, we compared the average difference in gene expression between each group of lung samples taken at each timepoint post-EVLP to those taken at end cold ischemia prior to starting EVLP. For each of the five group comparisons and for each gene probe set,
we calculated the average gene expression change and the corresponding statistical significance using the exact permutation test with 100 000 permutations. (Table 1) . This cohort was selected by identifying consecutive EVLP lungs from brain-dead donors which were transplanted following EVLP. Brainarray was utilized for annotations. 12 Given that these biopsies post-EVLP were taken at mean 4.2 hours, SD 0.37 of EVLP time, the results were compared to the 3 hours time course data. As per our current clinical standard, 500 mL of perfusate was exchanged for fresh after the 1st hour and then 250 mL every hour thereafter. performed. Kyoto Encyclopedia of Genes and Genomes (KEGG) was also utilized to confirm IPA findings. 
| RE SULTS

| EVLP
| Canonical pathways
The identification of important genes simply from the magnitude of change as described above is an oversimplification and bound to be an incomplete story. Canonical pathway analysis examines gene expression changes within the context of known gene pathways.
The canonical pathways that were most changed with time were "granulocyte adhesion" and "diapedesis". At 12 hours, there was significant upregulation in genes IL1, IL1R, SELE, and CSF3 and downregulation in genes SELL, Mac1, LFA1, and NAP2. Upregulated genes were found in the endothelial cell side of the pathway, while downregulated genes were predominantly found in the circulating cell side of the pathway ( Figure 3 ). This pattern is consistent with circulating leukocytes being washed away and filtered out during EVLP.
EVLP is a dynamic process and not a closed system, and as such, much of the identified "down-regulation" could alternatively 
| Downstream analysis
Canonical pathway analysis only represents currently highly understood pathways. To explore all of the genes identified by STEM as a whole, we performed a downstream analysis in IPA. This analysis predicts the overall biological trend based on the effect of each individual gene expression change as far as it is known in the current literature.
At 1 hour of EVLP, decreases in leukocyte chemotaxis, migration, and movement are predicted. This is in keeping with the aforementioned decreases in leukocyte genes due to washout. Indeed, some form of leukocyte chemotaxis is predicted to decrease at all time points sampled.
More interesting are the predicted increases over the 12 hours of EVLP. In the first hour, there is a strong prediction of increased cell death, necrosis and apoptosis. However, by the third hour of EVLP, the situation is reversed. Apoptosis is predicted to be decreased and the strongest predicted activated function is instead cell survival and cell regeneration. By hour 6 of EVLP, the overall predicted genetic profile remains that of survival and regeneration, with a trend towards more regenerative or organizational changes such as the invasion and migration of cells. At hours 9-12, the major signal found is an increase in the "invasion of cells" along with "epithelial and endothelial formation." Table 3 contains the top five predictions (where available) with an absolute z-score greater than 2.
| Upstream analysis
Upstream analysis is confounded by the washout of cells during EVLP. Much of the observed decreased gene expression changes are not secondary to regulated gene expression but rather to EVLP itself. Hence, unsupervised upstream analysis is unable to distinguish between the two and thus reveals a large number of uninterpretable upstream regulators (Table 4) .
| Validation analysis
The 15 paired newer samples matched closely the findings from the time-course microarray data at 3 and 6 hours. The top canonical pathway remained "granulocyte adhesion and diapedesis," and downstream analysis showed a top increased activation state of "Invasion of cells" which appears at 6 hours and a top decreased activation state of "damage of lung" and "organismal death," similar to that seen at 3 and 6 hours ( Table 3 ). The top three increased genes were CXCL8 (IL-8), CSF3, and IL1B, and the top three decreased genes were GPR34, KIAA0408, and HBB. Many of these show up among the 3 or 6 hours timepoints of the original dataset (Table 2 ).
| KEGG analysis
To help validate the IPA data, we used KEGG pathway analysis. The top 5 KEGG pathways were "leukocyte transendothelial migration," "cell adhesion molecules," "circadian rhythm," "phosphatidylinositol signaling system," and "adherens junction," similar to the IPA findings.
| D ISCUSS I ON
In this study, we performed a one-sample longitudinal time course analysis of microarray data obtained from rejected human lungs studies over 12 hours of normothermic ex vivo lung perfusion.
These lungs all had clinically acceptable physiological measures at the end of 12 hours EVLP, suggesting that they represent a clinically relevant sample of lungs that we today might have transplanted following EVLP evaluation. Indeed, many of the lungs were rejected in that era due to clinical concern for "pneumonia," but we helped mitigate the effect of any existing pneumonia in our data by perfusing the better lung and using only lungs which were stable for 12 hours on EVLP. This suggests that pneumonia probably was not significant, if it existed.
We chose to utilize the Affymetrix GeneChip Human Genome U133 Plus 2.0 array because it is a well-characterized microarray with established tools for its analysis. To minimize pre-processing, particularly statistical correction of batch effects, we performed RNA extraction and microarray hybridization as a single batch.
Unfortunately, this meant excluding one lung due to poor RNA quality following extraction. Microarray data remains expensive to obtain and thus we felt that samples taken every 3 hours, with an extra time point at 1 hour to represent early perfusion, would be the best compromise between cost and descriptive utility.
By and far, the strongest signal obtained from this study is that there is a reduction in the propagation of pro-inflammatory signaling within the lung during EVLP. While endothelial markers of inflammation and chemokine attractants are elevated, this is to be expected as the lung has experienced donor death related injury, cold ischemia and is exposed to foreign circuit material. More interesting, however, are the downstream mediators of these pro-inflammatory stimuli within the lung. Among the top ten most down-regulated genes are CCL2, CCL3, CCR1, and CCR2, all of which represent leukocyte factors. Indeed, the major canonical pathway identified by IPA is that of granulocyte and agranulocyte adhesion and diapedesis.
Observation of the pathway demonstrates a clear pattern where endothelial genes are elevated and leukocyte genes are decreased. that at subsequent hours. It is the only timepoint where cell death, including necrosis and apoptosis, is the predominant prediction from the genetic profile. This suggests that cellular injury accumulated during donor death and cold ischemic storage results in cell death, and their clearance early on in EVLP. By the third hour, the strongest predicted activation has become that of cell viability and cell survival. Cellular tight junction recovery seen by immunohistochemistry in our other report was supported here by the upregulation of the tight junction canonical pathway. 19 Indeed, this implies that normothermic acellular EVLP is not just "slowing death" as in static cold ischemic preservation, but actually allowing for cellular recovery. Moreover, the change from death to survival by 3 hours is significant clinically as this represents our empirically chosen minimum EVLP time to determine stability of function before making our final decision to move to implantation.
Defining the maximum perfusion time is more difficult. While we found no evidence of cell stress at 12 hours, the genetic profiles leaned towards cellular invasion, suggesting that outside circulating cells were being desired. It is enticing to think that the exogenous addition of stem cells to EVLP at this time could fulfill this need. Studies with longer EVLP times will need to be performed to explore this issue.
We recognize that there are limitations inherent in the design of this study. This experiment is limited by the resolution of the Affymetrix microarray. We are also largely dependent on the quality of gene annotation provided by IPA for interpretation of the data.
While this experimental design allows us to track the changes in gene expression over time on the EVLP circuit, it is necessarily limited by the lack of a control group. Indeed, a control group of a set of lungs transplanted into a recipient or a comparison group of these same lungs following implantation would be valuable, but impossible and unethical to obtain. Finally, because the lungs utilized in this study were all clinically rejected, few in number, and represent a very heterogeneous group, we did not examine the gene expression in lungs which failed 12 hours EVLP. Instead, a future study comparing lungs clinically accepted for EVLP which fail during EVLP to those that do not would be a much better comparison.
We recognize that only nine lungs were utilized for the study.
However, these are highly unique samples; lungs that today would likely be transplanted following EVLP evaluation were instead used for 12 hours of EVLP in a research protocol (development of clinical EVLP). To help validate the data generated, we collected biopsies from an additional 15 lungs clinically utilized for EVLP and then transplanted. We do not have a 12 hours time-course for these lungs as we perfuse lungs clinically for 4-6 hours. However, to validate, we compared the findings to the 3 hours timepoint of our timecourse data. We were very reassured to find that despite utilizing a new Affymetrix platform (Clariom D), a third-party annotation (Brainarray), and a newer version of IPA, very similar findings were identified when compared to the 3 and 6 hours timepoints, suggesting that the time-course dataset is generally sound.
In conclusion, this study has begun to elucidate the changes occurring in donor lungs during normothermic acellular EVLP. The general genetic expression changes towards reduced leukocyte migration and cellular recovery are encouraging and may explain the observed clinical improvement seen in our experience in EVLP treated lungs. More importantly, it suggests that the mechanisms underlying this benefit are nonspecific, related to innate recovery capabilities of the lung, and could be generalizable to the entire population of available donor lungs. Future directions might include examining the benefit of EVLP for acceptable lungs, identifying key and novel pathways for lung recovery, and finding genetic recovery pathways amenable to therapeutic enhancement.
